Articles |
From the Department of Physiology and Medicine, University of Antwerp (Belgium).
Correspondence to Dirk L. Brutsaert, MD, PhD, Department of Physiology and Medicine, University of Antwerp, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
Abstract Cardiac endothelium, both coronary and endocardial, produces a number of inotropic molecules. Changes in cardiac endothelial function by substances in the superfusing blood may thus participate in the control of muscle-pump performance of the heart. Reactive oxygen species (ROS) have been implicated in normal and pathological vascular physiology by influencing vascular endothelial function. Therefore, we examined the influence of ROS on endocardial endothelial modulation of myocardial performance. Right ventricular cat papillary muscles were briefly (15 s) exposed to electrolysis-generated ROS. Peak total isometric twitch tension and peak rate of tension development increased by 7.8±0.7% (P<.05) and 9.7±1.5% (P<.05), respectively (n=12). Isometric twitch duration was slightly increased (time from stimulus to half isometric relaxation, +2.7±0.6%; P<.05). ROS scavengers such as ascorbic acid (n=6), superoxide dismutase and catalase (n=8), or catalase alone (n=6), but not superoxide dismutase alone (n=6), blocked the inotropic effect. Interestingly, the positive inotropic effect was completely blocked by selectively damaging endocardial endothelium (Triton X-100, 0.5%, 1-s immersion, n=7) before ROS generation and by preincubating the muscles with the endothelin-A receptor antagonist BQ 123 (n=11). Preincubation with NG-nitro-L-arginine methyl ester and indomethacin (n=5) or with atenolol (n=6) did not influence the inotropic effect. Confocal scanning laser microscopic observations of muscles stained with viability tracers (n=9) revealed that significantly more but not all endocardial endothelial cells were damaged in electrolysis-treated muscles than in control muscles (42±5% versus 14±4%, P<.05). Accordingly, brief exposure of isolated cardiac muscle to electrolysis-generated ROS damaged the endocardial surface in part and increased contractile performance by stimulating endothelin release from endocardial endothelium. Hence, ROS-induced endothelin release from endocardial endothelium may be involved in normal and/or disturbed regulation of cardiac function.
Key Words: free radicals endocardial endothelium endothelial dysfunction endothelin cardiac muscle
This article has been cited by other articles:
![]() |
P. Castro-Chaves, R. Fontes-Carvalho, M. Pintalhao, P. Pimentel-Nunes, and A. F. Leite-Moreira Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart Exp Physiol, June 1, 2009; 94(6): 665 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fransen, R. R Lamberts, J. Hendrickx, and G. W De Keulenaer Endocardial endothelium modulates subendocardial pHi of rabbit papillary muscles: role of transendothelial HCO3- transport Cardiovasc Res, September 1, 2004; 63(4): 700 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mebazaa, G. W. De Keulenaer, X. Paqueron, L. J. Andries, P. Ratajczak, S. Lanone, C. Frelin, D. Longrois, D. Payen, D. L. Brutsaert, et al. Activation of Cardiac Endothelium as a Compensatory Component in Endotoxin-Induced Cardiomyopathy: Role of Endothelin, Prostaglandins, and Nitric Oxide Circulation, December 18, 2001; 104(25): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. TAVERNIER, A. MEBAZAA, P. MATEO, S. SYS, R. VENTURA-CLAPIER, and V. VEKSLER Phosphorylation-dependent Alteration in Myofilament Ca2+ Sensitivity but Normal Mitochondrial Function in Septic Heart Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 362 - 367. [Abstract] [Full Text] |
||||
![]() |
V. J. Thannickal and B. L. Fanburg Reactive oxygen species in cell signaling Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. De Keulenaer, M. Ushio-Fukai, Q. Yin, A. B. Chung, P. R. Lyons, N. Ishizaka, K. Rengarajan, W. R. Taylor, R. W. Alexander, and K. K. Griendling Convergence of Redox-Sensitive and Mitogen-Activated Protein Kinase Signaling Pathways in Tumor Necrosis Factor-{alpha}-Mediated Monocyte Chemoattractant Protein-1 Induction in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, February 1, 2000; 20(2): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-E. Massart, J. Donckier, J. Kyselovic, T. Godfraind, G. R. Heyndrickx, and M. Wibo Carvedilol and Lacidipine Prevent Cardiac Hypertrophy and Endothelin-1 Gene Overexpression After Aortic Banding Hypertension, December 1, 1999; 34(6): 1197 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. U Sys, G. W De Keulenaer, and D. L Brutsaert Physiopharmacological evaluation of myocardial performance: how to study modulation by cardiac endothelium and related humoral factors? Cardiovasc Res, July 1, 1998; 39(1): 136 - 147. [Full Text] [PDF] |
||||
![]() |
I. Lahaie, P. Hardy, X. Hou, H. Hassessian, P. Asselin, P. Lachapelle, G. Almazan, D. R. Varma, J. D. Morrow, L. J. Roberts II, et al. A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2alpha on retinal vessels Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1998; 274(5): R1406 - R1416. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Colucci Myocardial Endothelin : Does It Play a Role in Myocardial Failure? Circulation, March 15, 1996; 93(6): 1069 - 1072. [Full Text] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |